← Back to Search

Prebiotic-containing Formula

Experimental Infant Formula for Infant Development

N/A
Waitlist Available
Research Sponsored by Abbott Nutrition
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up sday 1 to sday 56
Awards & highlights

Study Summary

This trial will study how well a preterm infant formula with a prebiotic helps babies grow and if they can tolerate it.

Eligible Conditions
  • Infant Development

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~sday 1 to sday 56
This trial's timeline: 3 weeks for screening, Varies for treatment, and sday 1 to sday 56 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weight
Secondary outcome measures
Formula Intake
Head Circumference
Length
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental Infant FormulaExperimental Treatment1 Intervention
Ready-to-feed, milk-based formula

Find a Location

Who is running the clinical trial?

Abbott NutritionLead Sponsor
168 Previous Clinical Trials
33,453 Total Patients Enrolled
1 Trials studying Infant Development
245 Patients Enrolled for Infant Development
Michelle Johnson, RDN, LDStudy ChairAbbott Nutrition

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025